Financhill
Back

Palantir Technologies, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy
61

PLTR
Palantir Technologies, Inc.

Last Price:
$187.91
Seasonality Move:
5.45%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Buy
61
Palantir Technologies, Inc. (PLTR) is a Buy

Is Palantir Technologies, Inc. a Buy, Sell or Hold?

  • The current Palantir Technologies, Inc. [PLTR] share price is $181.84. The Score for PLTR is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • PLTR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

PLTR Stock Price Chart

What is Palantir Technologies, Inc.'s stock price today?

  • The Palantir Technologies, Inc. share price today is $181.84
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLTR is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

PLTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 56.69 Buy
Chaikin Money Flow: 3451072 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (163.97 - 184.71) Buy
Bollinger Bands (100): (160.28 - 185.68) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.72 - 73.96) Buy
Bollinger Bands (100): (43.27 - 64.19) Buy

PLTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 175.72 Buy
20-day SMA: 171.66 Buy
50-day SMA: 179.37 Buy
200-day SMA: 142.93 Buy
8-day EMA: 176.76 Buy
20-day EMA: 174.94 Buy
50-day EMA: 175.26 Buy
200-day EMA: 145.61 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

Palantir Technologies, Inc. Earnings Growth & PLTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.27 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

Palantir Technologies, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):